β-Blocker-Induced Liver Injury: A Class Effect With Incidental Rechallenge

Drug-induced liver injury is a common cause of acute liver failure. β-blockers are a widely prescribed class of medications; however, hepatotoxicity is a rare adverse effect of this medication of which clinicians must be aware. This case suggests that hepatotoxicity may be a class effect of β-blocke...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitchell, Natalie E., Harner, William, Laczek, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145213/
https://www.ncbi.nlm.nih.gov/pubmed/32309473
http://dx.doi.org/10.14309/crj.0000000000000273
_version_ 1783519956783071232
author Mitchell, Natalie E.
Harner, William
Laczek, Jeffrey
author_facet Mitchell, Natalie E.
Harner, William
Laczek, Jeffrey
author_sort Mitchell, Natalie E.
collection PubMed
description Drug-induced liver injury is a common cause of acute liver failure. β-blockers are a widely prescribed class of medications; however, hepatotoxicity is a rare adverse effect of this medication of which clinicians must be aware. This case suggests that hepatotoxicity may be a class effect of β-blockers.
format Online
Article
Text
id pubmed-7145213
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer
record_format MEDLINE/PubMed
spelling pubmed-71452132020-04-17 β-Blocker-Induced Liver Injury: A Class Effect With Incidental Rechallenge Mitchell, Natalie E. Harner, William Laczek, Jeffrey ACG Case Rep J Case Report Drug-induced liver injury is a common cause of acute liver failure. β-blockers are a widely prescribed class of medications; however, hepatotoxicity is a rare adverse effect of this medication of which clinicians must be aware. This case suggests that hepatotoxicity may be a class effect of β-blockers. Wolters Kluwer 2019-11-26 /pmc/articles/PMC7145213/ /pubmed/32309473 http://dx.doi.org/10.14309/crj.0000000000000273 Text en Written work prepared by employees of the Federal Government as part of their official duties is, under the U.S. Copyright Act, a “work of the United States Government” for which copyright protection under Title 17 of the United States Code is not available. As such, copyright does not extend to the contributions of employees of the Federal Government. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Case Report
Mitchell, Natalie E.
Harner, William
Laczek, Jeffrey
β-Blocker-Induced Liver Injury: A Class Effect With Incidental Rechallenge
title β-Blocker-Induced Liver Injury: A Class Effect With Incidental Rechallenge
title_full β-Blocker-Induced Liver Injury: A Class Effect With Incidental Rechallenge
title_fullStr β-Blocker-Induced Liver Injury: A Class Effect With Incidental Rechallenge
title_full_unstemmed β-Blocker-Induced Liver Injury: A Class Effect With Incidental Rechallenge
title_short β-Blocker-Induced Liver Injury: A Class Effect With Incidental Rechallenge
title_sort β-blocker-induced liver injury: a class effect with incidental rechallenge
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145213/
https://www.ncbi.nlm.nih.gov/pubmed/32309473
http://dx.doi.org/10.14309/crj.0000000000000273
work_keys_str_mv AT mitchellnataliee bblockerinducedliverinjuryaclasseffectwithincidentalrechallenge
AT harnerwilliam bblockerinducedliverinjuryaclasseffectwithincidentalrechallenge
AT laczekjeffrey bblockerinducedliverinjuryaclasseffectwithincidentalrechallenge

Ejemplares similares